Appili Therapeutics Inc. announced that Sean McBride, a 26 year pharmaceutical veteran, has joined the company as Vice President, Business Development. Mr. McBride will lead Appili’s out-licensing, product in-licensing and acquisition opportunities as the company builds its pipeline of infectious disease products. Mr. McBride brings more than two decades of experience within the Canadian pharmaceutical and biotechnology industry. His expertise lies in licensing, purchasing and divesting assets, in addition to advancing the commercialization of early stage assets and identifying opportunities for growth. Prior to joining Appili, Mr. McBride spent 10 years at GlaxoSmithKline Inc. (GSK) serving in many roles of increasing responsibility. Most recently he served as head of an entrepreneurial business unit where he negotiated global asset transactions and was responsible for the commercial success of over 40 brand assets. Prior to joining GSK, Mr. McBride served as a director for healthcare agencies conducting commercial and strategic assessments in both Canada and the US and also served as director of marketing with Roche Pharmaceuticals.